tiprankstipranks
Trending News
More News >

Percheron Therapeutics Warns Shareholders of Unauthorized Proxy Forms

Story Highlights
Percheron Therapeutics Warns Shareholders of Unauthorized Proxy Forms

Don’t Miss TipRanks’ Half Year Sale

Percheron Therapeutics ( (AU:PER) ) has shared an announcement.

Percheron Therapeutics has alerted its shareholders about unauthorized correspondence from Powerhouse Ventures Limited, which included a pre-filled proxy form for an upcoming General Meeting. The company emphasized that these proxy forms, if not submitted directly to the company’s share registry, may be invalid, and urged shareholders to follow proper procedures to ensure their votes are counted.

More about Percheron Therapeutics

Percheron Therapeutics Limited is a publicly listed biotechnology company focused on developing and commercializing novel therapies for rare diseases. Its lead program, avicursen (ATL1102), targets the CD49d receptor and has been investigated for inflammatory conditions like multiple sclerosis and Duchenne muscular dystrophy.

Technical Sentiment Signal: Sell

Current Market Cap: $8.34M

For an in-depth examination of PER stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1